Baxter GMP Trouble: Filter Changes In Gammagard Production Draw FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Problems relating to clogging events at its Belgium-based BioScience site include making process changes without submitting them to FDA.